Literature DB >> 27889844

Long-term use of the wearable cardioverter-defibrillator: prolonging life or prolonging indecision?

Evan Adelstein1.   

Abstract

Mesh：

Year:  2016        PMID： 27889844     DOI： 10.1007/s10840-016-0212-8

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  12 in total

1.  Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).

Authors:  Valentina Kutyifa; Arthur J Moss; Helmut Klein; Yitschak Biton; Scott McNitt; Bonnie MacKecknie; Wojciech Zareba; Ilan Goldenberg
Journal:  Circulation       Date:  2015-08-27       Impact factor: 29.690

Review 2.  Current evidence base for use of the implantable cardioverter-defibrillator.

Authors:  Stefan H Hohnloser; Carsten W Israel
Journal:  Circulation       Date:  2013-07-09       Impact factor: 29.690

Review 3.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Authors:  Roderick Tung; Peter Zimetbaum; Mark E Josephson
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

Review 4.  Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).

Authors:  Helmut U Klein; Ulf Meltendorf; Sven Reek; Jan Smid; Sebastian Kuss; Iwona Cygankiewicz; Christian Jons; Steven Szymkiewicz; Frank Buhtz; Anke Wollbrueck; Wojciech Zareba; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

5.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

Authors:  Stefan H Hohnloser; Karl Heinz Kuck; Paul Dorian; Robin S Roberts; John R Hampton; Robert Hatala; Eric Fain; Michael Gent; Stuart J Connolly
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

6.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

7.  National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.

Authors:  Madhab Lamichhane; Joseph C Gardiner; Nicole R Bianco; Steven J Szymkiewicz; Ranjan K Thakur
Journal:  J Interv Card Electrophysiol       Date:  2016-10-17       Impact factor: 1.900

8.  Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.

Authors:  Arthur M Feldman; Helmut Klein; Patrick Tchou; Srinivas Murali; W Jackson Hall; Donna Mancini; John Boehmer; Mark Harvey; M Stephen Heilman; Steven J Szymkiewicz; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2004-01       Impact factor: 1.976

9.  Defibrillator implantation early after myocardial infarction.

Authors:  Gerhard Steinbeck; Dietrich Andresen; Karlheinz Seidl; Johannes Brachmann; Ellen Hoffmann; Dariusz Wojciechowski; Zdzisława Kornacewicz-Jach; Beata Sredniawa; Géza Lupkovics; Franz Hofgärtner; Andrzej Lubinski; Mårten Rosenqvist; Alphonsus Habets; Karl Wegscheider; Jochen Senges
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

10.  Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.

Authors:  Madhurmeet Singh; Norman C Wang; Sandeep Jain; Andrew H Voigt; Samir Saba; Evan C Adelstein
Journal:  J Am Coll Cardiol       Date:  2015-12-15       Impact factor: 24.094
View more
  1 in total

1.  Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?

Authors:  Boldizsar Kovacs; Sven Reek; Nazmi Krasniqi; Urs Eriksson; Firat Duru
Journal:  Cardiol Res Pract       Date:  2018-11-29       Impact factor: 1.866
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.